This is a summary of the European public assessment report (EPAR) for Fampyra. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Fampyra. For practical information about using Fampyra, patients should read the package leaflet or contact their doctor or pharmacist.
Therapeutic Indication
Fampyra is indicated for the improvement of walking in adult patients with multiple sclerosis with walking disability (Expanded Disability Status Scale 4\-7\).
Therapeutic Area (MeSH)
ATC Code
N07XX07
ATC Item
N/A
Pharmacotherapeutic Group
Other nervous system drugs
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| Fampridine | N/A | Fampridine |
EMA Name
Fampyra
Medicine Name
Fampyra
Aliases
N/ANo risk management plan link.
